BOLT BIOTHERAPEUTICS INC (BOLT)

US0977021049 - Common Stock

1.16  -0.04 (-3.35%)

After market: 1.2 +0.04 (+3.45%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
1.26M
447.83%		5.73M
354.76%		7.876M
37.45%		9.131M
15.93%
EBITDA
YoY % growth
-91.6M
-88.59%		-88.65M
3.22%		-74.342M
16.14%		-96.49M
-29.79%		N/AN/AN/AN/A
EBIT
YoY % growth
-92.79M
-88.67%		-90.32M
2.66%		-76.196M
15.64%		-89.079M
-16.91%
Operating Margin
-7,364.29%-1,576.27%-967.45%-975.57%
EPS
YoY % growth
-3.14-2.36
24.84%		-1.83
22.46%		-1.79
2.04%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.50
-12.20%
Revenue
Q2Q % growth		2.105M
15.03%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-20.867M
-13.29%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.47
11.32%		-0.490.024.34%
Q3 2023
Q2Q % growth		 -0.43
25.86%		-0.510.0815.69%
Q2 2023
Q2Q % growth		 -0.48
21.31%		-0.500.023.30%
Q1 2023
Q2Q % growth		 -0.45
29.69%		-0.520.0713.78%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 2.089M
48.16%		1.747M342K19.58%
Q3 2023
Q2Q % growth		 2.53M
19.91%		1.76M770K43.75%
Q2 2023
Q2Q % growth		 1.43M
2.88%		1.939M-509K-26.25%
Q1 2023
Q2Q % growth		 1.83M
125.93%		1.332M498K37.39%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS4.81% 4.81% -7.16% -7.82%
Revenue37.58% 37.58% 75.6% 53.88%